ALLIANCEBERNSTEIN L.P. - RA PHARMACEUTICALS INC ownership

RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 70 filers reported holding RA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of RA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$14,894,000
-37.7%
310,218
-39.1%
0.01%
-21.4%
Q4 2019$23,888,000
+30.4%
509,009
-34.3%
0.01%
+27.3%
Q3 2019$18,320,000
+1442.1%
774,645
+1861.1%
0.01%
+1000.0%
Q2 2019$1,188,000
+99.3%
39,500
+48.5%
0.00%
Q1 2019$596,000
+29.6%
26,600
+5.1%
0.00%
Q4 2018$460,000
+46.0%
25,300
+45.4%
0.00%
Q3 2018$315,000
+115.8%
17,400
+18.4%
0.00%
Q2 2018$146,000
-25.1%
14,700
+41.3%
0.00%
Q2 2017$195,00010,4000.00%
Other shareholders
RA PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 5,493,636$54,662,0002.56%
RA Capital Management 3,851,808$38,325,0002.49%
VHCP Management II, LLC 544,612$5,419,0001.62%
Novo Holdings A/S 1,465,838$14,585,0001.47%
Consonance Capital Management LP 1,454,761$14,475,0000.93%
Rock Springs Capital Management LP 750,000$7,463,0000.29%
Eventide Asset Management 388,000$3,861,0000.16%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 382,700$3,808,0000.13%
Tekla Capital Management LLC 219,952$2,189,0000.08%
FIRST MANHATTAN CO. LLC. 777,487$7,735,0000.04%
View complete list of RA PHARMACEUTICALS INC shareholders